Evidence map›Paper›PMID 34259943›Full record

ArticleJournal of molecular modeling2021

Role of acceptor guests in tuning optoelectronic properties of benzothiadiazole core based non-fullerene acceptors for high-performance bulk-heterojunction organic solar cells.

Muhammad Yasir Mehboob, Riaz Hussain, Zobia Irshad, Muhammad Adnan

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Muhammad Yasir MehboobDepartment of Chemistry, University of Okara, Okara, 56300, Pakistan.ORCID http://orcid.org/0000-0002-7143-1129
Riaz HussainDepartment of Chemistry, University of Okara, Okara, 56300, Pakistan.
Zobia IrshadGraduate School, Department of Chemistry, Chosun University, Gwangju, 501-759, Republic of Korea. chem.zobia@gmail.com.
Muhammad AdnanGraduate School, Department of Chemistry, Chosun University, Gwangju, 501-759, Republic of Korea. adnan5750@gmail.com.ORCID http://orcid.org/0000-0001-9224-3824

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, end-capped acceptors tailoring approach has attracted many researchers because of unceasing higher power conversion efficiencies (PCEs) of resulted compounds. By keeping in view, the crucial role of NFAs in bulk-heterojunction OSCs, herein, we molecularly engineered five new non-fullerene acceptor materials (Y6A1-Y6A5) by modifying a recently synthesized Y6 molecule (R), having 18% power conversion efficiency when combined with D18 donor polymer. The structural-elemental connection, physical-chemical, optoelectronic, and photovoltaic characteristics of novel deigned and reference material (R) are studied with advanced quantum-chemical modulations. Density functional theory and time dependent-density functional theory has been employed through various basis sets to investigate the designed molecules theoretically. Interestingly, all of the newly modeled materials displayed lower excitation energies with lower HOMO-LUMO energy-gaps in-contrast with R molecule. Moreover, a red-shifted absorption and lower reorganizational energies of electron and hole are also a novel feature of these designed materials. The lower binding energy values of modeled materials offers better charge separation and high photo-current density (J

Indexed as

Bulk-heterojunction organic solar cellsEnd-capped acceptorsNon-fullerene acceptorPhotovoltaic propertiesPower conversion efficiency

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.